71 – 80 of 166
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Shared familial aggregation of susceptibility to different manifestations of venous thromboembolism: a nationwide family study in Sweden.
(
- Contribution to journal › Letter
- 2011
-
Mark
Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry.
(
- Contribution to journal › Article
-
Mark
The insulin receptor substrate 4 gene (IRS4) is mutated in paediatric T-cell acute lymphoblastic leukaemia.
(
- Contribution to journal › Letter
-
Mark
Long term risk of infections in Hodgkin lymphoma long-term survivors.
(
- Contribution to journal › Letter
-
Mark
Higher risk of primary cancers after polycythaemia vera and vice versa.
(
- Contribution to journal › Letter
-
Mark
Individualized toxicity-titrated 6-mercaptopurine increments during high-dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukaemia. A Nordic Society of Paediatric Haematology and Oncology (NOPHO) pilot study.
(
- Contribution to journal › Article
-
Mark
Irreversible pan-ERBB inhibitor canertinib elicits anti-leukaemic effects and induces the regression of FLT3-ITD transformed cells in mice.
(
- Contribution to journal › Article
-
Mark
Paediatric B-cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols.
(
- Contribution to journal › Article
-
Mark
Cytogenetic and molecular genetic characterization of the 'high hyperdiploid' B-cell precursor acute lymphoblastic leukaemia cell line MHH-CALL-2 reveals a near-haploid origin.
(
- Contribution to journal › Letter
- 2010
-
Mark
Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy
(
- Contribution to journal › Article